Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.02 USD | -4.60% | -0.73% | +125.61% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
Evolution of the average Target Price on Cullinan Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cullinan Therapeutics, Inc.
Morgan Stanley | |
SVB Leerink | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- CGEM Stock
- Consensus Cullinan Therapeutics, Inc.